LEVEL OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) URIN AS A PREDICTOR OF ACUTE KIDNEY INJURY IN SEPSIS PATIENTS TREATED IN ICU H.ADAM MALIK MEDAN HOSPITAL

Dr. Yudhistira, Burhanuddin Nasution, Achsanuddin Hanae, Nindia Sugih Arto

Abstract


BACKGROUND: Sepsis is a complex interaction between the direct toxic effects of infecting microor
ganisms and the disruption of the host's normal inammatory response to infection. One organ that is
often disrupted is the kidney . Neutrophil Gelatinase-Associated Lipocalin (NGAL) is an AKI biomarker that can be used as an
early biomarker for AKI prediction, monitoring clinical trials in AKI and for the prognosis of AKI.
METHOD: This research is an observational study. 30 subjects with sepsis were examined for PCT, BUN, urea, creatinine and
urine NGAL tests.
RESULTS: Statistical analysis using the Spearman Rank Test shows that NGAL level 1 has a signicant relationship with PCT
day 1, with a value (r = 0.912) and a value of p <0.05. NGAL level day 1 did not have a signicant relationship with levels of
urea, creatinine, BUN with values (r = 0.113), (r = 0.329), (r = 0.352) and values (p> 0.05). NGAL day 3 had a signicant
relationship with PCT day 1, with a value (r = 0.0771) and a p value <0.001. Measurement of NGAL day 3 had a signicant
relationship with urea, creatinine, BUN, and values (r = 0.427), (r = 0.550), (r = 0.411) with a p value <0.05.
CONCLUSIONS AND RECOMMENDATIONS: From the results of the study, it was concluded that there was a difference
between urine NGAL levels in septic patients on day 1 (197.26 ± 118.54) and day 3 (288.31 ± 136.96). There was a signicant
correlation between urinary NGAL levels with urea levels (p = 0.024 & r = 0.427) and creatinine (p = 0.002 & r = 0.550) on day 3,
so urine NGAL was a predictor of AKI events in sepsis patients on day 1 -3..


Keywords


Sepsis, Aki, Ngal

Full Text:

PDF

References


Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41:580–637.

Fleischmann C, Scherag A, Adhikari NK, et al. International Forum of Acute Care Trialists. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2015

de Geus HR, Betjes MG, Schaick R and Groeneveld JA: Plasma NGAL similarly predicts acute kidney injury in sepsis and nonsepsis. Biomarkers Med 7: 415-421, 2013.

Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest 2015;68:89–94.

Bellomo R, Ronco C, Mehta RL, Asfar P. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Bellomo et al. Ann. Intensive Care (2017) 7:49

Hamed-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2015;24(11):3349–3354

Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA, et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015; 65:860–9.

Lopes J, Jorge S, Resina C, Santos C, Pereira I, Neves J, Antunes F, et al. Acute kidney injury in patients with sepsis: a contemporary analysis. International Journal of Infectious Diseases. 2016;13: 176—181

Fodor C, Scherag A, Adhikari NK, et al. International Forum of Acute Care Trialists. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2015

Ghonemy TA and Amro GM: Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery. Saudi J Kidney Dis Transpl 25: 582-588, 2014.

Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA, et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015; 65:860–9.

Lopes J, Jorge S, Resina C, Santos C, Pereira I, Neves J, Antunes F, et al. Acute kidney injury in patients with sepsis: a contemporary analysis. International Journal of Infectious Diseases. 2016;13: 176—181

Lagos-Arevalo P, Palijan A, Vertullo L, Devarajan P, Bennett MR, Sabbisetti V, Bonventre JV, Ma Q, Gottesman RD and Zappitelli M: Cystatin C in acute kidney injury diagnosis: Early biomarker or alternative to serum creatinine? Pediatr Nephrol 30: 665-676, 2015

Lameire N, Biesen WV, Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol. 2016;17:923-5.

Marshall JC, Naqbi AL. Principles of source control in the management of sepsis. Crit Care Nurs Clin North Am. 2014 Mar;23(1):99-114.

Mandelbaum T, Scott DJ, Lee J, Mark RG, Malhotra A, Waikar SS, et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med. 2014; 39:2659–64.

Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307–315

Merik EP, Taeb MA. qSOFA and new sepsis definition. J Thorac Dis. 2017 Apr; 9(4): 943–945

Parikh AG, Moledina DG, Coca SG, Philbrook TS and Garg AX. Application of new acute kidney injury biomarkers in human randomized controlled trials. Kidney International. 2016 ;89: 1372–1379

Rennie TJW, De Souza N, Donnan PT, Marwick CA, Davey P, Dreischulte T, et al. Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series. Nephrol Dial Transplant. 2018 Jun 28


Refbacks

  • There are currently no refbacks.